Skip to main content
Fig. 8 | BMC Complementary Medicine and Therapies

Fig. 8

From: Antibiofilm and anticancer activities of unripe and ripe Azadirachta indica (neem) seed extracts

Fig. 8

Evaluation of cell viability of multidrug-resistant breast cancer cell MDA-MB-231 treated with control drug gemcitabine (C), unripe neem seed (U) and ripe neem seed (R) extract by MTT assay. IC50 dosage against selected cancer cells for control drug Gemcitabine (C) was found to be 200 µg/mL, whereas the same for unripe (U) and ripe (R) seed extracts were 30 µg/mL and 10 µg/mL, respectively

Back to article page